Pfizer says vaccine safe, effective on adolescents in trial
Reuters, 01 Apr 2021
Pfizer Inc and BioNTech SE said their COVID-19 vaccine was safe and effective and produced robust antibody responses in 12 to 15-year olds, paving the way for them to seek approval in the U.S. and Europe in weeks.
Reuters brings you the latest business, finance and breaking news video from around the globe. Our reputation for accuracy and impartiality is unparalleled.
Get the latest news on: http://reuters.com/
Follow Reuters on Facebook: https://www.facebook.com/Reuters
Follow Reuters on Twitter: https://twitter.com/Reuters
Follow Reuters on Instagram: https://www.instagram.com/reuters/?hl=en